반응식
[C:1]([O:5][C:6](=[O:26])[NH:7][C@H:8]1[CH2:12][CH2:11][N:10](CC2C=C3C(C=CN=C3N)=CC=2)[C:9]1=[O:25])([CH3:4])([CH3:3])[CH3:2].[NH2:27][C:28]1[C:33]2[CH:34]=[C:35]([CH2:37][NH2:38])[O:36][C:32]=2[CH:31]=[CH:30][N:29]=1>>[C:1]([O:5][C:6](=[O:26])[NH:7][C@H:8]1[CH2:12][CH2:11][N:10]([NH:38][CH2:37][C:35]2[O:36][C:32]3[CH:31]=[CH:30][N:29]=[C:28]([NH2:27])[C:33]=3[CH:34]=2)[C:9]1=[O:25])([CH3:2])([CH3:3])[CH3:4]참가 물질
3
실험 절차
Using the procedure described in example 85i 166 mg of 4-amino-2-(aminomethyl)furo[3,2-c]pyridine was transformed into 150 mg of the title compound. MS ESI+: 347 (M+H).
출처 및 근거
- ORD 기록
- ord-184aa78e301a493792379015e1fd8cce
- 출처 데이터셋
- uspto-grants-2002_09
- 특허 번호
- US06444672B1
연결된 노트
불러오는 중…